论文部分内容阅读
目的:分析对乳腺癌化疗后白细胞减少症患者实施益气升白汤的疗效。方法:将我院40例乳腺癌化疗后白细胞减少患者随机性分为观察组以及对照组,对照组患者使用利血生治疗,观察组患者使用益气升白汤治疗。结果:观察组患者在治疗后的白细胞计数以及升白细胞有效率均明显的优于对照组患者,所有差异均为显著差异,P<0.05,有统计学意义。结论:对乳腺癌化疗后白细胞减少症患者治疗时,使用益气升白汤能够起到更加有效的临床治疗效果,有着极高临床应用价值。
Objective: To analyze the efficacy of Yiqi Shengbai decoction on patients with leucopenia after chemotherapy for breast cancer. Methods: Forty patients with leukopenia after chemotherapy for breast cancer in our hospital were randomly divided into observation group and control group. Patients in control group were treated with reserpine. Patients in observation group were treated with Yiqisibai decoction. Results: The white blood cell count and the effective rate of leukocyte in the observation group were significantly better than those in the control group after treatment, all differences were significant differences (P <0.05, statistically significant). Conclusion: The treatment of leukopenia patients with breast cancer chemotherapy, the use of Yi Sheng Sheng Bai Tang can play a more effective clinical treatment, has a very high clinical value.